Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic

被引:7
|
作者
Purkayastha, T
Wasi, F
Shuter, J
机构
[1] Montefiore Med Ctr, AIDS Ctr, Dept Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA
关键词
D O I
10.1089/apc.2005.19.785
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clinical trials commonly measure rates of virologic suppression at a specific time point, whereas sustained virologic suppression is the goal of highly active antiretroviral therapy (HAART). We explored factors associated with sustained virologic suppression in an urban clinic population. The study population was drawn from patients who enrolled in Montefiore Medical Center's Infectious Diseases Clinic from 1999 to 2000. A computerized query of the hospital information system generated a list of potential case patients having every HIV-1 viral load (VL) less than 50 copies per milliliter throughout 2002 (at least three VL measurements were required), and a list of potential controls who failed to demonstrate sustained virologic suppression during 2002. Demographic and clinical information were collected by chart review, and case and control patient characteristics were compared by both univariate and multivariate analyses. Sixty-four case patients were compared to 64 controls. There were no significant differences in age, gender, ethnicity, type of antiretroviral therapy, or frequency of clinic visits. During the year of the study, cases experienced a significantly greater rise in CD4(+) lymphocyte counts than controls (108 cells per microliter versus 27 cells per microliter). On univariate analysis, factors associated with sustained virologic suppression included risk behavior other than heterosexual contact or injection drug use, being a non-smoker, and hepatitis C seropositivity. On logistic regression analysis, factors independently associated with sustained virologic suppression were risk behavior other than heterosexual contact or injection drug use (IDU), and hepatitis C seropositivity. In this study sample, being a nonsmoker, having a risk behavior for HIV acquisition other than heterosexual contact or IDU, and being seropositive for hepatitis C were associated with sustained virologic suppression. Computerized query of the hospital information system proved to be a powerful tool for the identification of study patients in a real-world clinic environment.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 50 条
  • [31] Antiretroviral therapy prescribing in hospitalized HIV clinic patients
    Rao, N.
    Patel, V.
    Grigoriu, A.
    Kaushik, P.
    Brizuela, M.
    HIV MEDICINE, 2012, 13 (06) : 367 - 371
  • [32] Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
    Sharma, Bechan
    CURRENT HIV RESEARCH, 2014, 12 (01) : 13 - 21
  • [33] Nutritional Intervention for Patients With HIV Receiving Antiretroviral Therapy
    Davila, Mila Gonzalez
    Polanco, Victor Puac
    Segura, Luis
    Kingsbury, Diana
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2018, 108 (11) : 1431 - 1431
  • [34] Clinic-Level Factors Associated With Time to Antiretroviral Initiation and Viral Suppression in a Large, Urban Cohort
    Monroe, Anne K.
    Happ, Lindsey P.
    Rayeed, Nabil
    Ma, Yan
    Jaurretche, Maria J.
    Terzian, Arpi S.
    Trac, Kevin
    Horberg, Michael A.
    Greenberg, Alan E.
    Castel, Amanda D.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : E151 - E158
  • [35] The Interplay of Sociodemographic Factors on Virologic Suppression Among a US Outpatient HIV Clinic Population
    Shacham, Enbal
    Nurutdinova, Diana
    Onen, Nur
    Stamm, Katelin
    Overton, E. Turner
    AIDS PATIENT CARE AND STDS, 2010, 24 (04) : 229 - 235
  • [36] Trust in Primary Care Providers and Antiretroviral Adherence in an Urban HIV Clinic
    Blackstock, Oni J.
    Addiso, Dianne N.
    Brennan, Jennifer S.
    Alao, Oladipo A.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2012, 23 (01) : 88 - 98
  • [37] Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
    Greub, G
    Cozzi-Lepri, A
    Ledergerber, B
    Staszewski, S
    Perrin, L
    Miller, V
    Francioli, P
    Furrer, H
    Battegay, M
    Vernazza, P
    Bernasconi, E
    Günthard, HF
    Hirschel, B
    Phillips, AN
    Telenti, A
    AIDS, 2002, 16 (14) : 1967 - 1969
  • [38] Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression
    Swindells, Susan
    DiRienzo, A. Gregory
    Wilkin, Timothy
    Fletcher, Courtney V.
    Margolis, David M.
    Thal, Gary D.
    Godfrey, Catherine
    Bastow, Barbara
    Ray, M. Graham
    Wang, Hongying
    Coombs, Robert W.
    McKinnon, John
    Mellors, John W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07): : 806 - 814
  • [39] Clinical Outcome of HIV Infected Patients Receiving Antiretroviral Therapy with Immunologic-Virologic Discordance (2012-2016)
    Abbasian, Ladan
    Ashtiani, Masoumeh Farrokh
    Najafi, Zeinab
    Seyedalinaghi, SeyedAhmad
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2019, 7 (01): : 9 - 14
  • [40] Clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy in outpatient HIV clinic
    So-Ngern, A.
    Manosuthi, W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S72 - S72